Jan 8 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC: BELIEVES IT HAS SUFFICIENT CASH, CASH
EQUIVALENTS
AND AVAILABLE RESOURCES TO FUND COMMERCIAL LAUNCH OF DEFENCATH
* CORMEDIX INC: ESTIMATES TIMING FOR DEFENCATH COMMERCIAL
AVAILABILITY AT APRIL 15, 2024 FOR INPATIENT SETTING
* CORMEDIX INC: ESTIMATES TIMING FOR DEFENCATH COMMERCIAL
AVAILABILITY AT NO SOONER THAN JULY 1, 2024 FOR OUTPATIENT
SETTING
* CORMEDIX INC- BELIEVES IT HAS SUFFICIENT CASH, CASH
EQUIVALENTS
AND AVAILABLE RESOURCES TO FUND COMMERCIAL LAUNCH
Source text for Eikon: ID:nGNXbtfRBV
Further company coverage: CRMD.O
((Reuters.Briefs@thomsonreuters.com;))